Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 23.90
+2.70 (12.74%)
At close: Dec 19, 2025
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 137.84 million as of December 19, 2025. Its market cap has decreased by -8.72% in one year.
Market Cap
137.84M
Enterprise Value
285.35M
Revenue
839.38K
Ranking
n/a
PE Ratio
5.26
Stock Price
23.90
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 137.84M, a decrease of -42.67%. That is a compound annual growth rate of -13.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 137.84M | -5.48% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 278.18B |
| Novartis AG | 208.23B |
| Galderma Group AG | 38.65B |
| Lonza Group AG | 37.42B |
| Alcon | 31.21B |
| Sandoz Group AG | 24.95B |
| Straumann Holding AG | 15.03B |
| Sonova Holding AG | 12.29B |